Symptom Management for Irritable Bowel Syndrome

Completed · Not applicable · Has a placebo group

Conditions studied: Irritable Bowel Syndrome

In brief

The objective of this study is to test the efficacy of a symptom management treatment strategy, Acupuncture/Moxibustion (Acu/Moxa), to improve the symptoms associated with Irritable Bowel Syndrome (IBS) in adults.

Key facts

Study ID

NCT02079857

Run by

NYU Langone Health

People needed

183

Starts

2012-11-01

Expected to finish

2019-11-01

Last updated by the study team

2020-07-28

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women 18 to 70 years of age.
• Diagnosis of IBS based on ROME III criteria.
• Complete symptom diaries and return completed diaries at all sessions.

You may not qualify if…

• History of co-existing gastrointestinal, and/or gynecological, and/or urologic pathology.
• Alarm symptoms according to ROME III.
• Individuals currently receiving other types of complementary therapies.
• Individuals with an acute medical condition requiring acute medical attention.

Where it is running

• NYU Division of Special Studies in Symptom Management — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.